Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.
about
Natalizumab: A new treatment for relapsing remitting multiple sclerosisInterferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis.IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotectionThe contribution of MRI in assessing cognitive impairment in multiple sclerosis.Is natalizumab a breakthrough in the treatment of multiple sclerosis?Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis.Treatment of neuropsychiatric conditions associated with multiple sclerosis.Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.Improvement of neuropsychological function in cognitively impaired multiple sclerosis patients treated with natalizumab: a preliminary study.Alemtuzumab in the treatment of multiple sclerosis.Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.The effect of interferon-beta on mouse neural progenitor cell survival and differentiation.A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing-remitting multiple sclerosis.
P2860
Q24683014-9BA28865-640E-4D09-A4F5-8C9C911BA07FQ33579409-48AB312D-8ABA-455C-BFCD-9FE360B65AD4Q33758016-F3B8B8FB-9A38-469B-806C-1113E270D212Q33764188-9A97F22F-DF4A-4FD1-AEAB-8FA0372AFBB4Q34202547-72125575-9E3C-43AB-AE98-1670735952F0Q35280670-B4461710-8343-45B0-AA85-5870C08F14EDQ35342948-8F1BE56C-93E6-4A04-A6AB-1F3B56CE4B0CQ35753383-2908C277-E356-455F-84CD-D3635D5ECA95Q36641533-8508FF8D-9C25-423C-BCD2-944BA13769E2Q37311605-AD56D914-F5A8-414F-938E-6A24A5D74B6AQ37442275-E4163C02-750B-4966-BE4F-A216FB292C30Q37649028-46133108-8CCB-4910-8B86-A7428FB12C28Q38050313-FF2EFFED-5242-4BFD-81B1-FB2C113B19D2Q40976248-A7503E0E-4E03-409E-9E2E-2E867E0F81C0Q44670939-808876B9-EAF8-494F-A980-E2C8C2A9C101
P2860
Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Immunomodulatory agents for th ...... clerosis: a systematic review.
@ast
Immunomodulatory agents for th ...... clerosis: a systematic review.
@en
Immunomodulatory agents for th ...... clerosis: a systematic review.
@nl
type
label
Immunomodulatory agents for th ...... clerosis: a systematic review.
@ast
Immunomodulatory agents for th ...... clerosis: a systematic review.
@en
Immunomodulatory agents for th ...... clerosis: a systematic review.
@nl
prefLabel
Immunomodulatory agents for th ...... clerosis: a systematic review.
@ast
Immunomodulatory agents for th ...... clerosis: a systematic review.
@en
Immunomodulatory agents for th ...... clerosis: a systematic review.
@nl
P1476
Immunomodulatory agents for th ...... clerosis: a systematic review.
@en
P2093
Andrew G Lee
Clyde Markowitz
P304
P356
10.1001/ARCHINTE.162.19.2161
P407
P577
2002-10-01T00:00:00Z